AraVasc Inc. |
Aravasc is developing a loco-regional multi-functional theranostic delivery system (MTDS). The MTDS is designed to deliver combination chemotherapeutics over several weeks, to the cancer site to avoid crippling systemic toxicities. It is also engineered to deliver a fluorescent dye that lights up the tumor vasculature enabling monitoring of the cancer therapy. The initial focus of the platform technology is in gastro-intestinal cancers. |